Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
Clinical trial NCT00675870 · UNKNOWN
Trial details
- NCT number
- NCT00675870
- Sponsor
- NuRx Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2010-04-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.